Research Grants 10,730 show all


$135.9M
2016

$152.6M
2017

$187.2M
2018

$171.2M
2019

$32.3M
2020

Patents 5,503show all

  • 1,849
    A61K - Preparations for medical, dental, or toilet purposes
  • 1,411
    C07K - Peptides
  • 886
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 825
    C12N - Microorganisms or enzymes
  • 688
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 325
    C07D - Heterocyclic compounds
  • 217
    A01K - Animal husbandry
  • 177
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 110
    C12Y - Enzymes
  • 82
    Y02A - Technologies for adaptation to climate change

Flintbox Opportunities 19show all

Dana-Farber Cancer Institute has 19 opportunities.

Publications 33,001 show all

  • 817
    Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • 724
    Antineoplastic Agents/therapeutic use
  • 450
    Breast Neoplasms/drug therapy
  • 387
    Mutation
  • 359
    Multiple Myeloma/drug therapy
  • 359
    T-Lymphocytes/immunology
  • 326
    Antineoplastic Agents/pharmacology
  • 324
    Neoplasms/therapy
  • 314
    Neoplasms/genetics
  • 307
    Neoplasms/drug therapy

Clinical Trials 2,825show all

1,083Phase 2604Phase 1386Phase 3304Phase 1/Phase 2209N/A50Other

Web Documents 444show all

Dana-Farber Cancer Institute has 444 documents.

Contact Information

Office of Research and Technology Ventures
450 Brookline Ave.
Boston, MA 02215-5450
United States